Clinical Trials Directory

Trials / Completed

CompletedNCT05788887

Investigation of the Postprandial Response of Two Different PDO Cheeses on Metabolic Biomarkers

Postprandial Inflammatory and Metabolic Responses Induced by the Authentic Ladotyri Mytilinis PDO Cheese and Italian Parmesan PDO Cheese

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
University of the Aegean · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The purpose of this study was the investigation of the postprandial metabolic responses, after the intake of a traditional, Ladotyri Mytilinis cheese, compared to corresponding responses after an Italian Parmesan cheese consumption, in healthy participants.

Detailed description

A pilot cross-over, randomized and single-blinded, intervention-clinical trial was conducted, in ten healthy men and women subjects, aged eighteen to thirty years, after random allocation into the control and the intervention group, received a high-fat and carbohydrates meal, containing Ladotyri Mytilinis (the authentic nonrefrigerated recipe) or Italian Parmesan, PDO cheeses. After a washout week, participants consumed the same meals, conversely. Differences on postprandial responses of serum total, High Density Lipoprotein (HDL-), Low Density Lipoprotein (LDL-) cholesterol, glucose, triglycerides and uric acid levels, as well as of plasma total antioxidant capacity according to Ferric Reducing Antioxidant Power method, were determined between groups in fasting, thirty minutes, one and a half hour, and three hours after meal intake.

Conditions

Interventions

TypeNameDescription
OTHERAuthentic Ladotyri Mytilinis PDO cheeseBranding PDO cheese from Mytilini, purchasing by E.Thimelis Dairy S.A.
OTHERControlBranding Parmesan PDO cheese from Italy, supplied by LIDL Hellas

Timeline

Start date
2022-01-10
Primary completion
2022-01-17
Completion
2022-01-17
First posted
2023-03-29
Last updated
2023-04-14

Locations

1 site across 1 country: Greece

Source: ClinicalTrials.gov record NCT05788887. Inclusion in this directory is not an endorsement.